Adherence to prevention and treatment therapeutics, as well as uptake and retention in care are critical challenges to sustained control of the HIV epidemic. Long-acting (LA) formulations designed to support long-term adherence and simplify treatment and prevention of HIV hold the promise of less burdensome therapeutic options, individual empowerment and wellbeing enhancement. Ensuring timely access to such game-changing innovations in low- and middle-income countries (LMICs) is key to minimize global health inequities. This satellite will provide an overview of LA products development and discuss opportunities and challenges for introduction of affordable LA solutions in HIV programmes in LMICs. The panel includes community representatives, industry and researchers focused on innovation in delivery methods, international implementing agencies, intergovernmental organizations and funders.

Access to sexual and reproductive health services and information, including a full range of contraceptive methods, is a fundamental human right critical to the well-being of women and girls. The ECHO study found no statistically significant increase in the risk of acquiring HIV between women using Cu IUD, LNG implant or DMPA IM. However, the study reported a high incidence of HIV, gonorrhea and chlamydia. To translate these research findings into policy WHO supported the formation of national task teams that brought together diverse stakeholders and had the mandate from Ministry of Health. This session highlights several aspects of the response showing the process, challenges and considerations. It is aimed at policy makers, program managers, advocates and researchers.

While HIV responses worldwide urgently need to revitalize their focus on the HIV prevention, diagnosis and treatment needs of key populations, the broader health needs of key populations also need to be recognized and addressed. Key population health needs extend to ensuring access to appropriate services for viral hepatitis and sexually transmitted infections (STIs) along with a broader package that includes mental health, transition care, substance use and sexual and reproductive health services. This session will explore new and emerging World Health Organization recommendations related to key populations across HIV, viral hepatitis, STIs and broader health. It will discuss the latest evidence and programmatic examples of providing person centered services to key populations in different settings through integrated services, service delivery, programming and funding that harnesses the synergies between the three diseases as well as broader health.

Adherence to prevention and treatment therapeutics, as well as uptake and retention in care are critical challenges to sustained control of the HIV epidemic. Long-acting (LA) formulations designed to support long-term adherence and simplify treatment and prevention of HIV hold the promise of less burdensome therapeutic options, individual empowerment and wellbeing enhancement. Ensuring timely access to such game-changing innovations in low- and middle-income countries (LMICs) is key to minimize global health inequities. This satellite will provide an overview of LA products development and discuss opportunities and challenges for introduction of affordable LA solutions in HIV programmes in LMICs. The panel includes community representatives, industry and researchers focused on innovation in delivery methods, international implementing agencies, intergovernmental organizations and funders.

Access to sexual and reproductive health services and information, including a full range of contraceptive methods, is a fundamental human right critical to the well-being of women and girls. The ECHO study found no statistically significant increase in the risk of acquiring HIV between women using Cu IUD, LNG implant or DMPA IM. However, the study reported a high incidence of HIV, gonorrhea and chlamydia. To translate these research findings into policy WHO supported the formation of national task teams that brought together diverse stakeholders and had the mandate from Ministry of Health. This session highlights several aspects of the response showing the process, challenges and considerations. It is aimed at policy makers, program managers, advocates and researchers.

While HIV responses worldwide urgently need to revitalize their focus on the HIV prevention, diagnosis and treatment needs of key populations, the broader health needs of key populations also need to be recognized and addressed. Key population health needs extend to ensuring access to appropriate services for viral hepatitis and sexually transmitted infections (STIs) along with a broader package that includes mental health, transition care, substance use and sexual and reproductive health services. This session will explore new and emerging World Health Organization recommendations related to key populations across HIV, viral hepatitis, STIs and broader health. It will discuss the latest evidence and programmatic examples of providing person centered services to key populations in different settings through integrated services, service delivery, programming and funding that harnesses the synergies between the three diseases as well as broader health.